We track 68 stocks in the Pharmaceuticals & Biotechnology industry (part of Healthcare), each checked every evening for a base — a stretch where the price moves sideways in a range instead of trending.
As of the latest close, 53 are still building a base; 5 broke out earlier and are still above the breakout level; 9 broke out but fell back below the breakout level; and 1 is not in a base we recognise.
The middle stock in this industry has a relative strength reading of 67 out of 99. That reading ranks each stock's price performance over the past year against every stock we track; half of this industry's 65 ranked stocks sit above 67 and half below. 28 stocks have a reading of 70 or higher.
52 of the 68 stocks we could measure (76%) closed above their 200-day average price — the average close over the last 200 trading sessions.